Company intelligence
Stellaromics Inc.
Helping the world see biology, in all dimensions.
About Stellaromics Inc.
Founded in 2022 and headquartered in Boston, Stellaromics is revolutionizing biomedical research with its proprietary technology, unraveling complex 3D transcription and translation patterns within native biological tissue. At the forefront of their innovation is STARmap (Spatially-resolved Transcript Amplicon Readout mapping), their flagship product. STARmap empowers researchers to uncover gene expression patterns within intact tissue, facilitating the pinpointing of treatment targets and bolstering biomedical investigations. Stellaromics is currently in the advanced stages of developing its Pyxa™ suite of products, meticulously crafted to empower researchers and clinicians in the creation of intricate cellular maps, thereby amplifying our comprehension of various diseases. For comprehensive details, we invite you to explore our website at stellaromics.com. Join us in shaping the future of biomedical research.
Verified activity
Signals from Stellaromics Inc.
5 published signals
People
Stellaromics Inc. is hiring a senior scientist for a computational oncology activity.
Reported by John Leamon
Research & Knowledge
Stellaromics Inc. published a white paper titled The Next Dimension of Discovery detailing the application of spatial biology and transcriptomics in measuring cell-cell adjacency in 5 µm and 100 µm thin and thick sections.
Reported by Stellaromics Inc.
Presence & Recognition
Stellaromics Inc. participated in the September Salem Days event at the Museum of Science on Tuesday, September 1.
Reported by Aliyah M. Weinstein, PhD